Irbesartan and Hydrochlorothiazide
- Product NDC
- 70518-2619
- 11-digit product format
- 705182619
- Labeler code
- 70518
- Product ID
- 70518-2619_dc64ef66-bb98-973a-e053-2995a90ad8bc
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Irbesartan and Hydrochlorothiazide
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA077369
- Marketing category
- ANDA
- Marketing start
- 2020-03-09
- Marketing end
- 0000-00-00
- Substance
- HYDROCHLOROTHIAZIDE; IRBESARTAN
- Active strength
- 13 mg/1; mg/1
- Pharmacologic classes
- Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-2619-0 | 70518261900 | 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70518-2619-0) | 2020-03-09 | 0000-00-00 | No | No | Current |